205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.12%
Revenue growth above 1.5x ADI's 1.46%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
223.36%
Gross profit growth above 1.5x ADI's 1.31%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
31.15%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
31.15%
Positive operating income growth while ADI is negative. John Neff might view this as a competitive edge in operations.
24.78%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
37.80%
Positive EPS growth while ADI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
37.80%
Positive diluted EPS growth while ADI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
14.90%
Share count expansion well above ADI's 7.12%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
14.90%
Diluted share count expanding well above ADI's 9.97%. Michael Burry would fear significant dilution to existing owners' stakes.
-75.13%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
35000.00%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
321.90%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
28.18%
10Y revenue/share CAGR at 50-75% of ADI's 55.93%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
17.88%
5Y revenue/share CAGR under 50% of ADI's 48.09%. Michael Burry would suspect a significant competitive gap or product weakness.
-2.29%
Negative 3Y CAGR while ADI stands at 14.26%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-82.91%
Negative 10Y net income/share CAGR while ADI is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-387.17%
Negative 5Y net income/share CAGR while ADI is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-184.17%
Negative 3Y CAGR while ADI is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
21.11%
10Y equity/share CAGR at 50-75% of ADI's 38.34%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
1.73%
Below 50% of ADI's 25.13%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
7.09%
3Y equity/share CAGR above 1.5x ADI's 3.33%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-15.75%
Cut dividends over 10 years while ADI stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-15.75%
Negative 5Y dividend/share CAGR while ADI stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
56.02%
3Y dividend/share CAGR of 56.02% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-12.39%
Firm’s AR is declining while ADI shows 5.32%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-5.12%
Inventory is declining while ADI stands at 6.07%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.55%
Negative asset growth while ADI invests at 4.51%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-20.60%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-4.73%
We’re deleveraging while ADI stands at 23.84%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
0.90%
SG&A declining or stable vs. ADI's 9.21%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.